1. Home
  2. MAIA vs WAVE Comparison

MAIA vs WAVE Comparison

Compare MAIA & WAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • WAVE
  • Stock Information
  • Founded
  • MAIA 2018
  • WAVE 2011
  • Country
  • MAIA United States
  • WAVE Israel
  • Employees
  • MAIA N/A
  • WAVE N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • WAVE Electric Utilities: Central
  • Sector
  • MAIA Health Care
  • WAVE Utilities
  • Exchange
  • MAIA Nasdaq
  • WAVE Nasdaq
  • Market Cap
  • MAIA 56.3M
  • WAVE 46.0M
  • IPO Year
  • MAIA 2022
  • WAVE 2021
  • Fundamental
  • Price
  • MAIA $1.58
  • WAVE $7.64
  • Analyst Decision
  • MAIA
  • WAVE Strong Buy
  • Analyst Count
  • MAIA 0
  • WAVE 1
  • Target Price
  • MAIA N/A
  • WAVE $15.00
  • AVG Volume (30 Days)
  • MAIA 398.8K
  • WAVE 26.4K
  • Earning Date
  • MAIA 08-11-2025
  • WAVE 08-14-2025
  • Dividend Yield
  • MAIA N/A
  • WAVE N/A
  • EPS Growth
  • MAIA N/A
  • WAVE N/A
  • EPS
  • MAIA N/A
  • WAVE N/A
  • Revenue
  • MAIA N/A
  • WAVE $168,000.00
  • Revenue This Year
  • MAIA N/A
  • WAVE $325.00
  • Revenue Next Year
  • MAIA N/A
  • WAVE $85.71
  • P/E Ratio
  • MAIA N/A
  • WAVE N/A
  • Revenue Growth
  • MAIA N/A
  • WAVE N/A
  • 52 Week Low
  • MAIA $1.40
  • WAVE $3.35
  • 52 Week High
  • MAIA $3.74
  • WAVE $17.63
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 45.57
  • WAVE 48.35
  • Support Level
  • MAIA $1.50
  • WAVE $7.55
  • Resistance Level
  • MAIA $1.73
  • WAVE $8.11
  • Average True Range (ATR)
  • MAIA 0.09
  • WAVE 0.55
  • MACD
  • MAIA 0.01
  • WAVE -0.16
  • Stochastic Oscillator
  • MAIA 42.86
  • WAVE 16.22

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.

Share on Social Networks: